Bleeding management in type 3 von Willebrand disease with anti‐von Willebrand factor inhibitor: A literature review and case report

Abstract Treatment of type 3 von Willebrand disease by infusion of von Willebrand factor (VWF) and factor VIII (FVIII) concentrates may lead to the development of anti‐VWF antibodies, challenging haemostasis management. The systematic review of the literature presented here retrieved 15 such cases (...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Aurélie Briane, Valérie Horvais, Marianne Sigaud, Marc Trossaërt, Nicolas Drillaud, Catherine Ternisien, Marc Fouassier, Antoine Babuty
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-10-01
Edice:	eJHaem
Témata:	allo‐antibodies bleeding disorders emicizumab haemostasis von Willebrand disease
On-line přístup:	https://doi.org/10.1002/jha2.984
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!